{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:clonazepam-tablet",
  "slug": "clonazepam-tablet",
  "title": "FDA shortage status: Clonazepam Tablet",
  "ingredient": "Clonazepam Tablet",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "CLONAZEPAM",
    "KLONOPIN"
  ],
  "therapeutic_categories": [
    "Neurology",
    "Pediatric",
    "Psychiatry"
  ],
  "dosage_forms": [
    "Tablet"
  ],
  "routes": [
    "ORAL"
  ],
  "package_count": 40,
  "packages": [
    {
      "package_ndc": "16729-136-00",
      "product_ndc": "16729-136",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 16729-136-00)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-136-16",
      "product_ndc": "16729-136",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 16729-136-16)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-137-00",
      "product_ndc": "16729-136",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 16729-137-00)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-137-16",
      "product_ndc": "16729-136",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 16729-137-16)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-138-00",
      "product_ndc": "16729-136",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 16729-138-00)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-138-16",
      "product_ndc": "16729-136",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 16729-138-16)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59651-722-01",
      "product_ndc": "59651-722",
      "company_name": "Aurobindo Pharma USA",
      "manufacturer_name": "Aurobindo Pharma Limited",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 59651-722-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/02/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59651-722-99",
      "product_ndc": "59651-722",
      "company_name": "Aurobindo Pharma USA",
      "manufacturer_name": "Aurobindo Pharma Limited",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 59651-722-99)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/02/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59651-723-01",
      "product_ndc": "59651-722",
      "company_name": "Aurobindo Pharma USA",
      "manufacturer_name": "Aurobindo Pharma Limited",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 59651-723-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/02/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59651-723-99",
      "product_ndc": "59651-722",
      "company_name": "Aurobindo Pharma USA",
      "manufacturer_name": "Aurobindo Pharma Limited",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 59651-723-99)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/02/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59651-724-01",
      "product_ndc": "59651-722",
      "company_name": "Aurobindo Pharma USA",
      "manufacturer_name": "Aurobindo Pharma Limited",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 59651-724-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/02/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59651-724-05",
      "product_ndc": "59651-722",
      "company_name": "Aurobindo Pharma USA",
      "manufacturer_name": "Aurobindo Pharma Limited",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 59651-724-05)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/02/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "61269-605-10",
      "product_ndc": "61269-605",
      "company_name": "Cheplapharm Arzneimittel GmbH",
      "manufacturer_name": "H2-Pharma, LLC",
      "presentation": "Klonopin, Tablet, .5 mg (NDC 61269-605-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "61269-610-10",
      "product_ndc": "61269-605",
      "company_name": "Cheplapharm Arzneimittel GmbH",
      "manufacturer_name": "H2-Pharma, LLC",
      "presentation": "Klonopin, Tablet, 1 mg (NDC 61269-610-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "61269-620-10",
      "product_ndc": "61269-605",
      "company_name": "Cheplapharm Arzneimittel GmbH",
      "manufacturer_name": "H2-Pharma, LLC",
      "presentation": "Klonopin, Tablet, 2 mg (NDC 61269-620-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-406-10",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 43547-406-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-406-11",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 43547-406-11)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-406-50",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 43547-406-50)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-407-10",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 43547-407-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-407-11",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 43547-407-11)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-407-50",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 43547-407-50)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-408-10",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 43547-408-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43547-408-50",
      "product_ndc": "43547-406",
      "company_name": "Prinston Pharmaceutical, Inc.",
      "manufacturer_name": "Solco Healthcare LLC",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 43547-408-50)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "07/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-152-00",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-00)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-152-01",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-152-05",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-05)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-152-30",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 72888-152-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-153-00",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 72888-153-00)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-153-01",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 72888-153-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/27/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-153-05",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 72888-153-05)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-153-30",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 72888-153-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-154-01",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 72888-154-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-154-05",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 72888-154-05)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72888-154-30",
      "product_ndc": "72888-152",
      "company_name": "Rubicon Research Private Limited",
      "manufacturer_name": "Advagen Pharma Ltd",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 72888-154-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0093-0832-01",
      "product_ndc": "0093-0832",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 0093-0832-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0093-0832-05",
      "product_ndc": "0093-0832",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Clonazepam, Tablet, .5 mg (NDC 0093-0832-05)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0093-3212-01",
      "product_ndc": "0093-0832",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 0093-3212-01)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0093-3212-05",
      "product_ndc": "0093-0832",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Clonazepam, Tablet, 1 mg (NDC 0093-3212-05)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0093-3213-01",
      "product_ndc": "0093-0832",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 0093-3213-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0093-3213-05",
      "product_ndc": "0093-0832",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Teva Pharmaceuticals USA, Inc.",
      "presentation": "Clonazepam, Tablet, 2 mg (NDC 0093-3213-05)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "03/10/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 39,
    "Limited Availability": 1
  },
  "initial_posting_date": "03/10/2023",
  "latest_source_update": "08/17/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}